Abstract  A photolabile precursor of the neuroinhibitory amino acid glycine has been synthesised with two phosphate groups attached to the indoline nucleus at a 4-alkoxy substituent. In common with the photochemical properties of other 1-acyl-7-nitroindolines, this releases glycine on a sub-s time scale upon irradiation with near-UV light. The synthetic route previously developed for the preparation of the GABA analogue required some modifications because of the greater hydrolytic sensitivity of the glycine compound. The phosphorylation method used here could be beneficial to the synthesis of other nitroindoline-caged amino acids, especially the related caged GABA derivative. Glycine released by laser photolysis on spinal cord neurons generated fast-rising responses and the pharmacological properties of the reagent are such that it is useful for physiological experiments. 
Introduction
The technique of liberating biologically active compounds from photolabile precursors, upon brief irradiation with near-UV light is a valuable tool for studies of biological processes. The method relies on the availability of suitable reagents, widely known as 'caged' compounds and their syntheses and applications are described in reviews. 1 These reagents must satisfy a number of prerequisites such as solubility and stability in aqueous media, high purity and pharmacological inertness prior to photolysis, rapid and efficient photolysis at neutral pH followed by fast dark reactions after photolysis, and no release of toxic by-products after photocleavage. Failure to fulfil any one of the above criteria usually renders a caged reagent inadequate for application in biological systems.
During the last decade we have produced a number of 7-nitroindoline-caged neuroactive amino acids, including L-glutamate 1 2 and 2, 3 -aminobutyrate (GABA) 3
and glycine 4, 4 L-aspartate 5, 5 and L-alanine 6, 6 which have been applied in various biological systems. Detailed pharmacological evaluation has found that caged glutamates 1 and 2 do not bind to glutamergic receptors prior to photolysis and are therefore suitable reagents for investigations of synaptic transmission. 4, 5, 7 They fulfil all the above criteria to a satisfactory extent, they are now commercially available and have been extensively applied in neuroscience. 8 In contrast, caged GABA 3 and caged glycine 4 were found to bind to their respective ionotropic GABA or glycine receptors * Keywords: Photolysis; Caged Compounds; Nitroindolines; Phosphorylation † The work described here is, in part, the subject of patent applications US Appl. 11/507961 and EP Appl. 06254350.4 *Corresponding author. Tel.: +44 20 8816 2407; fax: +44 20 8906 4477; e-mail address: gpapage@nimr.mrc.ac.uk on neuronal cells prior to photolysis, blunting the response to the photolyticallyreleased amino acid. 4, 7 A separate investigation has indicated that neither caged glycine 4 nor caged L-aspartate 5 inhibit the NMDA receptor, suggesting that reagent 4 might have useful application in studies of the effects of co-agonist binding to NMDA receptors. 5 Photolytic release of L-alanine from 6 has enabled the observation of alanine-induced pre-steady-state currents of three different neutral amino acid transporters. Photolysis of these reagents in aqueous solution proceeds with stoichiometric release of the amino acid, accompanied by the corresponding nitrosoindole by-product as shown in Scheme 1. A study of the photolysis mechanism 9 of 1-acyl-7-nitroindolines in aqueous solution determined the release rate of the amino acid as ~5  10 6 s -1 at ambient temperature, corresponding to a half-life of ~150 ns which is sufficiently rapid for mimicking biological processes. The advantageous photochemical properties and hydrolytic stability of 1-acyl-7-nitroindolines motivated us to seek means of eliminating or at least suppressing the adverse pharmacological properties of 3 and we have previously reported the synthesis and photochemical evaluation of the modified caged GABA reagent 7.
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The incorporation of a high concentration of negative charge close to the nitroindoline nucleus did not affect its photochemical properties. Furthermore, the structure retained the advantages of hydrolytic stability of the cage and its fast and efficient photorelease at near-UV and 405 nm wavelengths, but brought about a large reduction in the interaction of 7 with GABAA receptors. 11a Further detailed neurophysiological investigations 11b revealed the existence of a new class of miniature currents ("preminis") in developing interneurons that reflect the activation of presynaptic GABAA receptors following random vesicular release. 
8
The successful reduction of adverse pharmacological properties of 7 prior to photolysis opened the possibility that the same strategy might be applied to the glycine analogue 8. Various caged glycine derivatives have been reported by other workers 12 but have suffered from problems of instability or inadequate photolytic efficiency. We had anticipated that synthesis of the diphosphate nitroindoline (DPNI) glycine 8 would closely follow the route described for 7. In the event, a number of modifications were required, in part because of greater hydrolytic sensitivity of the amide bond in the glycine series of precursors. In addition, the method for introduction of the two phosphate groups was substantially improved over that previously described in the synthesis of 7. In the course of developing the synthesis, we also prepared the 4-methoxy compound 15 and in the process obtained some further insight into side reactions that occurred during nitration reactions of Nacylindolines.
Results and discussion
In our previous investigations 10 of a synthetic route to 7, we had found that di-Boc protection of the amino group in a GABA precursor had been ineffective in avoiding side reactions at this centre, although the same protection strategy had been effective for amino groups in precursors to 4-methoxy-7-nitroindoline derivatives of Lglutamate, 13 and L-alanine. 6 For the eventual successful synthesis of 7, the problem was avoided by masking the amino group as an azide that was converted to an amine at a late stage of the synthesis. Nevertheless, in view of the successful application of the di-Boc protection strategy for synthesis of L-alanine, we felt it was worthwhile to test the same methodology here. Using the 4-methoxy system, the route shown in Scheme 2 gave the di-Boc precursor 10. Homogeneous nitration, as used by us previously for related nitrations, 3b,6,13 gave a mixture in which the major component was the N-nitro species 11, isolated as a crystalline solid and characterised by 1 H NMR spectroscopy and elemental analysis (see Supplementary data). Although 5-and 7-mononitro isomers were also present in the reaction products, the substantial formation of 11 made this route unacceptable. It now appears that both steric and electronic effects are important in the ability of the double Boc protection to limit unwanted N-nitration, and we therefore returned to the azide strategy used for 7.
Given the somewhat unpredictable outcome of results with only minor changes in structure, we first tested the azide route by preparing the methoxynitroindoline-caged glycine 15, as shown in Scheme 3, both to validate the individual steps and to have a sample of 15 available for pharmacological testing in comparison with our intended target compound 8. Only two points of Scheme 3 deserve specific comment. First, the nitration of the azidoacetylindoline 13 was carried out using a minor modification of a reported procedure 14 (NaNO3 in place of LiNO3) in which scandium triflate acts as a catalyst for nitration. In practice, for this substrate there was no advantage in yield or regioselectivity over our previous claycop-mediated nitration procedure, 3b but the scandium triflate procedure was investigated as an alternative because of difficulties encountered during the synthesis of 8 (see below) and because we had previously found that the claycop procedure was ineffective with indolines bearing a bulky substituent at the 4-position. 10 The second point of note relates to the Staudinger reduction of the azide 14 that was carried out in aqueous DMF, as had been done at the final stage in synthesis of 8. In the latter case the initial product isolated had been an iminophosphorane, which required mild but prolonged acid treatment (pH 1 at room temperature overnight) to release the required amine. 10 In contrast, the reduction of 14 under the same conditions gave the amine directly upon work-up of the reaction mixture. As discussed below, the susceptibility to hydrolysis of the initial iminophosphorane product is remarkably idiosyncratic. With preparation of 15 readily achieved, we returned to the synthesis of 8 and, following similar methods to those in Scheme 3, readily obtained the azide 19 (Scheme 4). However, upon very brief alkaline treatment (25 mM NaOH for 2 min) which was intended to remove the acetate groups, a mixture of products was detected by TLC and UV-vis spectroscopy that indicated significant hydrolysis of the amide linkage had taken place. This contrasts with experience in the synthesis of the caged GABA 7, where hydrolysis of the corresponding acetates was readily achieved under very similar conditions, without detectable amide hydrolysis. Electron-withdrawal by the -azido substituent evidently makes the azidoacetyl amide bond much more sensitive to base hydrolysis and we subsequently found that the amide bond was ~10% hydrolysed at pH 7.0 overnight at room temperature (see details in Supplementary Data). To avoid the problem of amide hydrolysis, we instead carried out the hydrolysis step before nitration, since the amide bond in the non-nitrated indoline was expected to be much more stable. group, but Staudinger reaction using either triphenylphosphine or tri-n-butylphosphine in aqueous DMF failed to yield pure 8 even after prolonged mild acidic treatment of the reaction mixture. It was evident from HPLC data (not shown) that an iminophosphorane was formed, as in the case of the related caged-GABA synthesis, 10 but it was much more resistant to hydrolysis. This was particularly surprising since reduction of 14 under the same conditions had given the amine 15 directly upon mild acidic work-up (see above), implying ready hydrolysis of the iminophosphorane in that case. However, reduction of the azide 22 was successfully accomplished using the water-soluble tris(2-carboxyethyl)phosphine hydrochloride (TCEP) to give 8 in 47% yield after purification by anion-exchange chromatography, precipitation as its barium salt and reconversion to the sodium salt.
The photochemistry of both 8 and its model analogue 15 was similar to that of other N-acyl-7-nitroindolines. Continuous irradiation of separate solutions of 8 and 15, monitored by UV-vis spectroscopy, as described previously, 2,3a,10 showed progressive decrease of each starting compound and accumulation of the nitrosoindole chromophore. Clear isosbestic points were formed as photolysis progressed indicating a clean conversion (see Supplementary data). Photolysis of 8 was also monitored by HPLC and released glycine was measured by amino acid analysis, as described for related compounds. 2,3a Glycine recovery was in the range 68-69%. This was significantly below the essentially stoichiometric release reported for other 7-nitroindoline-caged amino acids and appears inconsistent with the clean spectroscopic data for the progressive photolysis but extensive investigations (data not shown) have not resolved this matter.
Neurophysiological recordings upon glycine release by near-UV laser photolysis
Glycine 
Conclusions
The synthesis of 8 was successfully accomplished but, despite its similarity to the previously described caged GABA 7, significant modification of the previously established synthetic route was required. The unexpected reactivity of the densely functionalised intermediate compounds was surmounted by employing more effective reagents and appropriate reaction conditions. The controlled nitration of indolines in synthesis of these caged compounds remains subject to a need for individual optimisation, while the improved phosphorylation method could usefully be applied to a better synthesis of the caged GABA 7.
Release of glycine on spinal cord neurons by localised laser photolysis of 8 showed fast activation of glycinergic currents with time-course in the ms range. Although slower than glycine mediated synaptic currents recorded in the same neurons, the kinetics of activation by photoreleased glycine are nonetheless fast enough to be useful in experiments to determine the distribution of glycine sensitivity in neuronal compartments and to yield kinetic data of glycine receptor function at synaptic sites in situ. A further appealing feature of 8 is that, contrary to the block of GABA (-aminobutyric acid) responses seen with the caged GABA analogue DPNI-GABA 7, DPNI-gly does not interact with the glycine receptors. The origin of the run-down of responses seen with multiple pulses of DPNI-glycine photolysis applied consecutively to the same sites was not elucidated in the experiments described here. The present synthesis has provided enough material for further pharmacological characterisation and these studies will be reported elsewhere in due course. 
1-(2-Bromoacetyl)-4-(1,3-diacetoxypropan-2-yloxy)indoline (17)
A solution of 
1-(2-Azidoacetyl)-4-(1,3-diacetoxypropan-2-yloxy)-7-nitroindoline (19)
To a solution of 18 (489 mg, 1.35 mmol) in a mixture of CH2Cl2 (13.5 mL) and acetic anhydride (27 mL) was added copper nitrate hemipentahydrate (365 mg, 1.75 mmol) and the mixture was stirred at rt overnight. The solution was concentrated and the residue was re-evaporated from toluene, diluted with EtOAc (50 mL) and washed with saturated aqueous NaHCO3 and brine, dried and evaporated to brown viscous oil. 
1-(2-Azidoacetyl)-4-[1,3-bis(dihydroxyphosphoryloxy)propan-2-yloxy]-7-nitroindoline (22)
To a solution of 21 (237 mg, 0.35 mmol) in dry MeCN (3.5 mL) was added acetic 
1-(2-Aminoacetyl)-4-[1,3-bis(dihydroxyphosphoryloxy)propan-2-yloxy]-7-nitroindoline (8)
A solution of 22 (191 mol) in water (3 mL) was diluted with DMF (27 mL) and mol). The solution was diluted with water (250 mL) to conductivity 5.3 mS cm -1 and subjected to anion-exchange chromatography using a linear gradient formed from 10 and 500 mM NaOAc, pH 6.0 (each 1000 mL). Fractions containing the product, which eluted at ~300 mM NaOAc, were analysed as above, combined (144 mL) and The stock solution (20.9 mM) was also subjected to quantitative amino acid analysis and the measured free glycine contamination was 0.35%. 
Supplementary Data
The experiments described here relate to the synthesis of the model compound 15 which were carried out as optimisation procedures for the synthesis of our target 
Experimental Details
Procedures related to Scheme 2.
1-[2-(tert-Butoxycarbonylamino)acetyl]-4-methoxyindoline (9)
To a solution of 4-methoxyindoline (3.73 g, 25 mmol; prepared as previously 
1-[2-(tert-Butoxycarbonylnitroamino)acetyl]-4-methoxy-7-nitroindoline (11)
A solution of 10 (2.03 g, 5 mmol) in a mixture of CH2Cl2 (50 mL) and acetic anhydride (75 mL) was treated with copper nitrate hemipentahydrate (1.28 g, 5.5 mmol) and stirred at rt overnight. The solution was concentrated and the residue was re-evaporated from toluene, diluted with EtOAc (50 mL) and washed with saturated aq. NaHCO3 and brine, dried and evaporated to give brown viscous oil. The product was dissolved in CH2Cl2 (50 mL), treated with 1 M TFA in CH2Cl2 (7.5 mL, 7.5 mmol) and stirred at rt overnight. The solvent was evaporated and the residue was Procedures related to Scheme 3.
1-(2-Bromoacetyl)-4-methoxyindoline (12)
A solution of 4-methoxyindoline (1.49 g, 10 mmol; prepared as previously described 1 ) in dry MeCN (50 mL) was treated with 2-bromoacetic acid (1.67 g, 12 mmol),
followed by 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (2.11 g, 11 mmol) and the mixture was stirred at rt under nitrogen overnight. The solvent was evaporated and the residue was taken up in EtOAc (50 mL) washed with dilute aq.
HCl, saturated aq. NaHCO3 and brine, dried and evaporated to pale crystals.
Recrystallisation (EtOAc-hexanes) followed by flash chromatography 
1-(2-Azidoacetyl)-4-methoxyindoline (13)
To a solution of 12 (2.16 g, 8 mmol) in dry DMF (60 mL) was added NaN3 (1.56 g, 24 mmol) and the mixture was stirred at rt overnight. 
1-(2-Azidoacetyl)-4-methoxy-7-nitroindoline (14)
To a solution of 13 (464 mg, 2 mmol) in dry MeCN (20 mL) was added acetic 
1-(2-Aminoacetyl)-4-methoxy-7-nitroindoline (15)
To a solution of 14 (227 mg, 1 mmol) in dry DMF (10 mL) was added water (1.1 mL) and triphenylphosphine (1.84 g, 7 mmol) and the mixture stirred at rt overnight. TLC HEPES, and 25 glucose, pH adjusted to 7.4 with NaOH. Kynurenic acid (3 mM) was added to the slicing solution to protect the tissue from glutamate excitotoxicity.
Electrophysiological recordings
To minimise usage of the DPNI-glycine, uncaging was done in HEPES-buffered saline without solution flow in the bath. Composition (mM) 135 NaCl, 4 KCl, 2 NaHCO3, 25 glucose, 2 CaCl2, 2 MgCl2 and 10 HEPES, pH 7.4. 2 mM NaHCO3 was present to help maintain intracellular pH. TTX 0.2 or 0.5 M, CNQX or NBQX 2 M and AP5 20 M were added to block excitation and ionotropic glutamate receptors.
Slices were transferred to a 0.5 mL recording chamber in HEPES-buffered saline and initially perfused at a flow rate of 1.5mL/min. O2 was blown over the surface of the bath to improve tissue survival and facilitate mixing. DPNI-glycine 8 was added from 20 mM stock solutions once a recording was obtained and the solution flow stopped. Interactions between DPNI-glycine and glycine receptors
The possibility that DPNI-glycine 8 might itself interfere with glycine synaptic transmission was tested by comparing the amplitude of spontaneous glycinergic synaptic events in the absence of 8 or its presence in the bath at 3 mM concentration.
An example of spontaneous glycinergic currents before and during application of 3 mM DPNI-glycine is shown in Figure S2A and S2B respectively. There is no difference in the average amplitude of synaptic response with or without DPNIglycine (from 89 ± 17 to 87 ± 17 pA, n = 12 cells, Figure S2D) . Similarly, the rise- and DPNI-GABA 5 reported previously.
